KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares RepurchasedShort-Term Debt repayments
Ratios

Elevance Health (ELV) Receivables Refunds (2016 - 2019)

Elevance Health (ELV) has disclosed Receivables Refunds for 11 consecutive years, with $91.0 million as the latest value for Q3 2019.

  • On a quarterly basis, Receivables Refunds rose 31.88% to $91.0 million in Q3 2019 year-over-year; TTM through Sep 2019 was $91.0 million, a 31.88% increase, with the full-year FY2018 number at $10.0 million, down 97.08% from a year prior.
  • Receivables Refunds was $91.0 million for Q3 2019 at Elevance Health, down from $296.0 million in the prior quarter.
  • In the past five years, Receivables Refunds ranged from a high of $342.0 million in Q4 2017 to a low of $9.0 million in Q2 2016.
  • A 5-year average of $147.1 million and a median of $122.8 million in 2018 define the central range for Receivables Refunds.
  • Peak YoY movement for Receivables Refunds: surged 102.73% in 2017, then tumbled 97.08% in 2018.
  • Elevance Health's Receivables Refunds stood at $316.6 million in 2015, then tumbled by 46.72% to $168.7 million in 2016, then soared by 102.73% to $342.0 million in 2017, then tumbled by 97.08% to $10.0 million in 2018, then surged by 810.0% to $91.0 million in 2019.
  • Per Business Quant, the three most recent readings for ELV's Receivables Refunds are $91.0 million (Q3 2019), $296.0 million (Q2 2019), and $10.0 million (Q4 2018).